Frontiers in Nutrition (Sep 2022)

Intestinal permeability of agaro-oligosaccharides: Transport across Caco-2 cell monolayers and pharmacokinetics in rats

  • Ikuya Shirai,
  • Ikuya Shirai,
  • Koji Karasawa,
  • Yusuke Kodaira,
  • Yu Iwasaki,
  • Yasutaka Shigemura,
  • Hidefumi Makabe,
  • Hidefumi Makabe,
  • Shigeru Katayama,
  • Shigeru Katayama

DOI
https://doi.org/10.3389/fnut.2022.996607
Journal volume & issue
Vol. 9

Abstract

Read online

Agaro-oligosaccharides (AOSs), even-numbered oligosaccharides prepared from agar, are applied to various food, including supplements, drinks, and jellies because of their biological activities. This study aimed to evaluate the AOS permeation in the gastrointestinal tract in vivo and in vitro. Agarobiose (Abi), agarotetraose (Ate), and agarohexaose (Ahe) were detected in rat plasma after oral administration of AOSs. The detection level of agarobiose in the plasma was higher than that of agarohexaose, which was consistent with the permeation study using Caco-2 cell monolayers. Further, the adenosine triphosphate inhibitor (sodium azide) or endocytosis inhibitor (colchicine) did not inhibit AOS permeation through Caco-2 cell monolayers. Conversely, AOS permeation enhanced upon treatment with cytochalasin B, a tight junction disrupter, suggesting that AOSs might have passed mainly through the tight junctions between the intestinal epithelial cells. These results indicate that AOSs, especially agarobiose, can be absorbed as an intact form via the gastrointestinal tract across the intestinal epithelium through the paracellular pathway.

Keywords